Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01690494 · ClinicalTrials.gov registry record · NA

Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders

A NA study of Substance-Related Disorders and Sexually Transmitted Diseases, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
480
Enrollment target
1
Study location

NCT01690494 is a NA study of Substance-Related Disorders and Sexually Transmitted Diseases that has completed, run by Columbia University. The registered enrollment target is 480 participants, below the 1,513-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01690494, a NA study of Substance-Related Disorders and Sexually Transmitted Diseases, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
480 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized controlled trial (RCT) that will rigorously evaluate the implementation, effectiveness and cost-effectiveness of a couple-based integrated human immunodeficiency virus (HIV) and drug abuse prevention intervention (Connect II) with drug-involved male offenders charged with misdemeanors and their primary female sexual partners, implemented by frontline providers in Criminal Court, Community Court or probation (CCP) sites in NYC, compared to CCP standard treatment of care services (TAU). The primary outcomes are to reduce sexually transmitted infections (STIs) and increase condom use.

Interventions

  • BEHAVIORAL TAU
  • BEHAVIORAL PACT

Study Locations (1)

New York

  • Columbia University - New York

Trial Details

FieldValue
Enrollment Target 480 participants
Start Date 2013-06-11
Est. Completion 2017-09-30
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT01690494

The ClinicalTrials.gov registry entry for NCT01690494 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,513-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (68% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which TAU is the first listed.

NCT01690494 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01690494 about?

NCT01690494 is a clinical study titled "Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders". This study is a randomized controlled trial (RCT) that will rigorously evaluate the implementation, effectiveness and cost-effectiveness of a couple-based integrated human immunodeficiency virus (HIV) and drug abuse prevention intervention (Connect II) with drug-involved male offenders charged with ...

What is the current status of trial NCT01690494?

This trial is currently completed. It is a NA study. The enrollment target is 480 participants. The study started on 2013-06-11. Estimated completion is 2017-09-30.

What conditions does trial NCT01690494 study?

This clinical trial studies the following conditions: Substance-Related Disorders, Sexually Transmitted Diseases, Unsafe Sex.

What interventions are being tested in trial NCT01690494?

The interventions under investigation include: TAU (BEHAVIORAL), PACT (BEHAVIORAL).

Who is sponsoring clinical trial NCT01690494?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01690494 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance-Related Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.